Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.967
-0.063 (-6.11%)
At close: Nov 20, 2024, 4:00 PM
0.988
+0.021 (2.15%)
Pre-market: Nov 21, 2024, 5:06 AM EST
Adicet Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -117.88 | -142.66 | -69.79 | -62 | -36.68 | -28.14 | |
Depreciation & Amortization | 6.53 | 6.1 | 2.58 | 1.54 | 1.23 | 1.24 | |
Other Amortization | 0.04 | 0.03 | 0.09 | 0.18 | 0.13 | - | |
Loss (Gain) From Sale of Assets | -0 | -0 | 0.05 | 0.03 | - | -0.03 | |
Asset Writedown & Restructuring Costs | - | 19.46 | - | 1.19 | 2.3 | - | |
Loss (Gain) From Sale of Investments | -0.28 | - | - | 0.01 | 0.01 | -0.2 | |
Stock-Based Compensation | 23.37 | 20.26 | 17.13 | 12.51 | 5.26 | 1.18 | |
Other Operating Activities | 3.14 | 2.84 | 2.43 | 1.55 | -0.28 | -2.27 | |
Change in Accounts Receivable | - | - | - | -0.03 | - | - | |
Change in Accounts Payable | -1.51 | -1.68 | 1.71 | 1.14 | -0.81 | 0.53 | |
Change in Unearned Revenue | - | - | -4.81 | -9.18 | -7.9 | -1 | |
Change in Other Net Operating Assets | -5.17 | 1.94 | 5.84 | 2.01 | -4.81 | 0.81 | |
Operating Cash Flow | -91.76 | -93.72 | -44.77 | -51.05 | -41.55 | -27.88 | |
Capital Expenditures | -1.08 | -4.46 | -16.78 | -13.05 | -0.99 | -1.07 | |
Sale of Property, Plant & Equipment | - | - | - | - | - | 0.12 | |
Cash Acquisitions | - | - | - | - | 64.11 | - | |
Investment in Securities | - | - | - | 10.25 | 52.09 | -46.98 | |
Investing Cash Flow | -1.08 | -4.46 | -16.78 | -2.8 | 115.22 | -47.93 | |
Issuance of Common Stock | 111.47 | 0.39 | 45.11 | 242.95 | 0.46 | 0.03 | |
Repurchase of Common Stock | -96.4 | -0.15 | -3.23 | - | - | - | |
Other Financing Activities | - | - | -0.36 | -0.26 | -0.16 | - | |
Financing Cash Flow | 15.07 | 0.24 | 41.51 | 242.69 | 0.3 | 76.95 | |
Net Cash Flow | -77.78 | -97.95 | -20.04 | 188.84 | 73.97 | 1.13 | |
Free Cash Flow | -92.84 | -98.18 | -61.55 | -64.1 | -42.54 | -28.95 | |
Free Cash Flow Margin | - | - | -246.29% | -658.77% | -237.62% | -2909.75% | |
Free Cash Flow Per Share | -1.22 | -2.28 | -1.50 | -2.07 | -5.81 | -13.54 | |
Cash Income Tax Paid | - | - | - | -2.72 | -0.66 | 0 | |
Levered Free Cash Flow | -53.56 | -61.28 | -38.41 | -42.27 | -11.79 | -19.98 | |
Unlevered Free Cash Flow | -53.6 | -61.3 | -38.45 | -42.33 | -11.84 | -19.98 | |
Change in Net Working Capital | 2.15 | 0.33 | -3.98 | 5.69 | -2.46 | 1.71 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.